Search - tctmd.com

Displaying 361 - 380 of 525

Sort: Relevancy | Date

News Daily News

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Yael L. Maxwell

August 12, 2015

News Daily News

BARI 2D: El Mayor Control de los Factores de Riesgo en Pacientes con Diabetes Tipo 2 Mejora Supervivencia

Yael L. Maxwell

August 12, 2015

News Daily News

BARI 2D：改善 2 型糖尿病患者的危险因素控制情况可以提高其生存率

Yael L. Maxwell

August 12, 2015

Presentation

Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial

Presenter: Vera Bittner

August 11, 2015

Presentation

EES vs CABG for Patients With Diabetes and Multivessel Disease

Presenter: Sripal Bangalore

July 30, 2015

Presentation

Incidence and Predictors of Unplanned Non-TLR Up to 3 Years After DES Implantation

Presenter: Mohamed Abdel-Wahab

July 23, 2015

News Industry News

Resverlogix Officially Attains Phase 3 Status with a European Regulatory Authority

June 22, 2015

News Industry News

First CVD Outcome Trial of a GLP-1 Agonist Finds No Cardiac Risk or Benefit

June 09, 2015

News Industry News

Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

June 05, 2015

News Conference News EuroPCR 2015

Evolving DES Technology May Benefit Diabetic Patients

Caitlin E. Cox

May 19, 2015

News Daily News

Un Estudio de ‘Pacientes No Seleccionados’ Revela un Beneficio sobre la Supervivencia derivado de Revascularizaciones Completas en Pacientes Con y Sin Diabetes

Caitlin E. Cox

May 08, 2015

News Daily News

“所有患者”研究表明完全血运重建能改善有或无糖尿病患者的生存率

Caitlin E. Cox

May 08, 2015

News Daily News

‘All-Comers’ Study Shows Survival Benefit of Complete Revascularization in Patients With, Without Diabetes

Caitlin E. Cox

May 08, 2015

Presentation

Long-term Prognosis of Complete Percutaneous Coronary Revascularization in Patients With Diabetes and Multivessel Disease

Presenter: MF. Jim?nez-Navarro

May 07, 2015

Advertisement

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

BARI 2D: El Mayor Control de los Factores de Riesgo en Pacientes con Diabetes Tipo 2 Mejora Supervivencia

BARI 2D：改善 2 型糖尿病患者的危险因素控制情况可以提高其生存率

Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial

EES vs CABG for Patients With Diabetes and Multivessel Disease

Incidence and Predictors of Unplanned Non-TLR Up to 3 Years After DES Implantation

Resverlogix Officially Attains Phase 3 Status with a European Regulatory Authority

First CVD Outcome Trial of a GLP-1 Agonist Finds No Cardiac Risk or Benefit

Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

Evolving DES Technology May Benefit Diabetic Patients

Un Estudio de ‘Pacientes No Seleccionados’ Revela un Beneficio sobre la Supervivencia derivado de Revascularizaciones Completas en Pacientes Con y Sin Diabetes

“所有患者”研究表明完全血运重建能改善有或无糖尿病患者的生存率

‘All-Comers’ Study Shows Survival Benefit of Complete Revascularization in Patients With, Without Diabetes

Long-term Prognosis of Complete Percutaneous Coronary Revascularization in Patients With Diabetes and Multivessel Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content